Zhongcai Financial Holding Investment
VC Fund
Beijing, China
Zhongcai Financial Holding Investment is an investment institution that focuses on equity investment and fund management. It is the holding company of China Finance Publishing Media Group, a unit directly under the Ministry of Finance. The company has its headquarters in Beijing with a registered capital of 100 million yuan. Its shareholding andholding companies have locations in more than ten cities in all major regions of China. The investment direction includes new media, new energy, internet, medical biology, electronic technology, modern agriculture and environmental protection, industry, and other hot industries. Zhongcai Financial Control has carried out multi-level and diversified strategic cooperation with a number of large central enterprises and outstanding private enterprises in the past six years. Among them, Zhongcai Fund Management that cooperates with China Investment Holdings and CIC Securities has launched the CIC Zhongcai Music Industry Fund and the Game Industry Fund that has established industry brand awareness. The company and the 360 Group formally established a strategic cooperation in 2016 to launch jointly the Zhongcai Qihoo Gold Control Internet Industry Investment Center that has location in the Internet financial platform and invests in leading projects in the industry. The company is responsible for the responsibility of state-owned enterprises at the same time. The subsidiary company has the honor to participate in the management of guiding funds in many provinces and municipalities such as Ningxia, Hainan, Jiangxi, Guangzhou, and others, filling the gaps in the private equity fund business in many local regions, and for local integration. The creation of the financial platform has contributed to one's own efforts. Zhongcai Hainan Fund and Zhongcai Ningxia Fund are the first private equity funds in the region. Zhonghao Jinkong Investment has become a relatively important integrated financial service platform in Yunnan Province.
- Total investments:
- 15
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Zhongcai Financial Holding Investment invests in
Stages Zhongcai Financial Holding Investment invests in
Countries Zhongcai Financial Holding Investment invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Pharmaceutical 5 (33%)
- Medical 4 (27%)
- Biopharma 4 (27%)
- Health Care 4 (27%)
- Biotechnology 3 (20%)
Stage
- Venture - Series Unknown 10 (67%)
- Seed 1 (7%)
- Series A 1 (7%)
- Series B 1 (7%)
- Series D 1 (7%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Bin Wang
General Manager of Zhongcai International
|
General Manager of Zhongcai International | Total investments: 0 | Find email | |
|
Shouyuan Wu
Chief Financial Officer
|
Chief Financial Officer | Total investments: 0 | Find email | |
|
Wei Wang
General Manager of Zhongcai Hainan
|
General Manager of Zhongcai Hainan | Total investments: 0 | Find email | |
|
Zhipeng Wang
Director of Investments
|
Director of Investments | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Zhongke Zidong Taichu is committed to general artificial intelligence (AGI) to accelerate the transformation of scientific and technological achievements into real productivity. | Venture - Series Unknown / May 16, 2025 | ||
| Listenai is an enterprise that provides AI chips and industry solutions for the field of artificial intelligence and the Internet of Things. | Venture - Series Unknown / Aug 23, 2023 | ||
| Beijing Zhongke Flux Technology Co., Ltd. is a provider of industrial Internet information infrastructure and solutions | Venture - Series Unknown / Jan 01, 2021 | ||
| ALPHAMA BIOTECHNOLOGY develops tailored computational models and algorithm logic for drug research and development. | Venture - Series Unknown / Jan 01, 2021 | ||
| Thousand Oaks Biopharmaceuticals is a developer of biopharmaceutical technologies intended to produce protein and vaccine compounds. The company's technologies provide integrated control solutions, including the use of technical expertise to optimize the process and increase protein expression to reduce production scale, providingbio-pharmaceutical companies with personalized, chemical-defined cell culture media, formula production, technical support and ancillary services. | Series B / Jul 24, 2020 | ||
| WATRIX is China’s leading artificial intelligence company focusing on computer vision and video big data analysis. In 2016, Watrix was incubated by Institute of Automation, Chinese Academy of Sciences (CASIA), and founded by Dr. Yongzhen Huang, etc. The founding team had more than 20 years’ in-depth research on computer vision.The coretechnologies of Watrix are the most advanced gait recognition technology and leading industrial vision technology. The company has provided mature AI solutions to security, transportation, manufacturing and other industries. | Venture - Series Unknown / May 01, 2020 | ||
| Platform-based information technology company | Venture - Series Unknown / Jan 01, 2019 | ||
| Qifu Technology is a financial technology company that provides digital solutions for financial institutions and consumers. Its products and services cover credit technology, risk control, anti-fraud systems, data analytics, and loan lifecycle support, including borrower acquisition and post-loan management, along with technology-enabled publicwelfare and financial inclusion services. | Venture - Series Unknown / Jan 01, 2019 | ||
| Huahui Health engages in the R&D of innovative drugs for digestive diseases such as hepatitis B, liver cancer, and pancreatic cancer. It has developed novel drug candidates for hepatitis B to achieve the ambitious goal of a functional cure. Leveraging outstanding competence and capabilities in discovery, early development, and antibodyengineering, Huahui Health has expanded its pipeline to include several "First-in-Class" and "Best-in-Class" drug candidates in virology and oncology.The company was founded in 2015 and is based in Changping, Beijing, China. | Venture - Series Unknown / Jan 01, 2018 | ||
| New Journey engages in the medical and health field that covers medical services, elderly care services, and pharmaceutical manufacturing. Headquartered in Beijing, New Miles Hospital Group has professional platforms such as New Miles Medical, Hongci Medical, Huayou Medical, etc. It is a leading medical and health industry group in China. 200primary medical institutions with a total of 30,000 beds. | Venture - Series Unknown / Jan 01, 2018 | ||
| See all 15 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Zhongcai Financial Holding Investment invest in?
Zhongcai Financial Holding Investment invests primarily in Pharmaceutical, Medical and Biopharma startups, most often at Venture - Series Unknown and Seed stage. Most of the 15 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Zhongcai Financial Holding Investment?
Public channels for Zhongcai Financial Holding Investment include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Zhongcai Financial Holding Investment?
The team at Zhongcai Financial Holding Investment includes Bin Wang (General Manager of Zhongcai International), Shouyuan Wu (Chief Financial Officer) and Wei Wang (General Manager of Zhongcai Hainan). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
